Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v2-FR
Language French French
Date Updated 2022-04-29 2022-03-23
Drug Identification Number 00784400 00784400
Brand name AA-AMILZIDE AA-AMILZIDE
Common or Proper name AA-AMILZIDE AA-AMILZIDE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients AMILORIDE HYDROCHLORIDE HYDROCHLOROTHIAZIDE AMILORIDE HYDROCHLORIDE HYDROCHLOROTHIAZIDE
Strength(s) 5MG 50MG 5MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1000BTL 100BTL
ATC code C03EA C03EA
ATC description DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-03-25 2022-03-25
Actual start date
Estimated end date 2022-05-05 2022-04-20
Actual end date 2022-04-27
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments